Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹8Cr
Refractories/Intermediates
Rev Gr TTM
Revenue Growth TTM
53.64%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

RASSIREF
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 61.6 | -74.2 | 51.9 | -51.7 | -41.5 | 318.4 | -31.2 | -71.7 | -9.3 | 10.7 | 33.5 | 732.3 |
| 17 | 4 | 12 | 9 | 12 | 10 | 9 | 4 | 10 | 10 | 15 | 20 |
Operating Profit Operating ProfitCr |
| 24.2 | -65.0 | 31.2 | -17.0 | 6.8 | -4.6 | 18.7 | -100.5 | 20.8 | 8.7 | 5.4 | -8.0 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 1 | -1 | 1 | 0 | 0 | 4 | 0 |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 5 | -2 | 5 | -2 | 0 | -1 | 1 | -2 | 2 | 0 | 4 | -2 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | 468.8 | 10.4 | 409.5 | -741.9 | -100.4 | 77.3 | -86.2 | -14.6 | 11,450.0 | 154.9 | 544.4 | 8.8 |
| 20.0 | -96.2 | 26.9 | -25.6 | -0.1 | -5.2 | 5.4 | -103.6 | 18.8 | 2.6 | 26.1 | -11.4 |
| 9.7 | -4.8 | 9.7 | -4.2 | 0.0 | -1.1 | 1.3 | -4.8 | 4.8 | 0.6 | 8.6 | -4.4 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| -12.4 | -26.8 | -25.2 | 200.9 | 89.7 | 16.9 | -56.6 | 200.8 | -6.1 | -31.7 | -11.4 | 58.9 |
| 29 | 12 | 6 | 16 | 36 | 44 | 18 | 60 | 55 | 37 | 34 | 54 |
Operating Profit Operating ProfitCr |
| -120.1 | -23.4 | 10.5 | 24.7 | 12.8 | 8.7 | 14.9 | 5.3 | 6.2 | 8.2 | 5.7 | 5.0 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 1 | 4 |
Interest Expense Interest ExpenseCr | 0 | 3 | 3 | 4 | 4 | 2 | 2 | 3 | 2 | 2 | 2 | 2 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| -17 | -2 | -3 | 1 | 4 | 2 | 0 | 1 | 1 | 0 | 0 | 4 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 |
|
| -376.3 | 85.8 | -32.1 | 121.7 | 488.4 | -70.0 | -71.1 | 227.6 | -24.9 | -65.7 | -69.9 | 4,984.2 |
| -128.3 | -24.9 | -43.9 | 3.2 | 9.8 | 2.5 | 1.7 | 1.8 | 1.5 | 0.7 | 0.3 | 8.0 |
| -34.6 | -5.1 | -6.7 | 1.4 | 8.5 | 2.6 | 0.8 | 2.4 | 1.8 | 0.6 | 0.2 | 9.6 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| -21 | -23 | -27 | -26 | -22 | -21 | -20 | -19 | -18 | -18 | -18 | -14 |
Current Liabilities Current LiabilitiesCr | 20 | 15 | 19 | 62 | 22 | 17 | 17 | 26 | 43 | 48 | 43 | 46 |
Non Current Liabilities Non Current LiabilitiesCr | 26 | 37 | 38 | 28 | 42 | 35 | 35 | 33 | 17 | 20 | 19 | 18 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 22 | 22 | 25 | 60 | 38 | 27 | 28 | 36 | 37 | 45 | 41 | 47 |
Non Current Assets Non Current AssetsCr | 8 | 11 | 10 | 9 | 9 | 9 | 9 | 8 | 9 | 9 | 8 | 8 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | -6 | 1 | 11 | 5 | 0 | 22 | 1 | 1 |
Investing Cash Flow Investing Cash FlowCr | 0 | 0 | -1 | 0 | 0 | -1 | 0 | 0 |
Financing Cash Flow Financing Cash FlowCr | 7 | -1 | -10 | -3 | 0 | -21 | 0 | -2 |
|
Free Cash Flow Free Cash FlowCr | -6 | 1 | 11 | 5 | 0 | 22 | 1 | 1 |
| -925.8 | 22.9 | 885.1 | 1,287.0 | 24.5 | 2,525.6 | 247.3 | 1,328.1 |
CFO To EBITDA CFO To EBITDA% | -118.6 | 17.5 | 257.6 | 144.7 | 8.5 | 599.7 | 22.0 | 57.9 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 4 | 8 | 5 | 2 | 3 | 0 | 4 | 7 | 4 | 19 | 12 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 2.4 | 0.8 | 0.0 | 11.5 | 6.3 | 4.3 | 64.9 | 129.0 |
Price To Sales Price To Sales | 0.3 | 0.8 | 0.7 | 0.1 | 0.1 | 0.0 | 0.2 | 0.1 | 0.1 | 0.5 | 0.3 |
Price To Book Price To Book | -0.3 | -0.4 | -0.2 | -0.1 | -0.2 | 0.0 | -0.3 | -0.5 | -0.3 | -1.4 | -0.9 |
| -1.8 | -18.7 | 54.1 | 8.0 | 10.3 | 10.4 | 14.5 | 15.3 | 8.0 | 14.0 | 20.0 |
Profitability Ratios Profitability Ratios |
| -86.3 | 28.6 | 62.9 | 55.5 | 29.5 | 42.3 | 59.4 | 32.6 | 25.0 | 28.3 | 27.1 |
| -120.1 | -23.4 | 10.5 | 24.7 | 12.8 | 8.7 | 14.9 | 5.3 | 6.2 | 8.2 | 5.7 |
| -128.3 | -24.9 | -43.9 | 3.2 | 9.8 | 2.5 | 1.7 | 1.8 | 1.5 | 0.7 | 0.3 |
| -213.3 | 2.4 | -2.4 | 19.4 | 21.6 | 13.8 | 10.4 | 9.9 | 24.4 | 16.1 | 13.0 |
| 104.3 | 12.9 | 14.6 | -3.3 | -23.5 | -7.6 | -2.3 | -8.0 | -6.3 | -2.2 | -0.7 |
| -57.1 | -7.2 | -9.2 | 1.0 | 8.7 | 3.4 | 1.0 | 2.6 | 1.9 | 0.6 | 0.2 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
**Raasi Refractories Limited (CIN: L26920TG1981PLC003339)** is an Indian industrial manufacturer specializing in high-performance refractory products. The company operates as a **single-segment** entity, primarily serving the heavy metal and mineral processing industries. While the company maintains a core manufacturing presence in the refractory sector, its research notes also indicate a specialized focus on pharmaceutical formulations developed through indigenous technology.
---
### **Core Manufacturing Infrastructure & Product Portfolio**
The company’s operational backbone is its manufacturing facility located at **Lakshmipuram, Narketpally, Nalgonda District, Telangana**. The business model is vertically integrated, covering the lifecycle from production to customer delivery with an emphasis on cost-efficiency.
**Refractory Solutions:**
The company produces materials essential for high-temperature industrial processes, including:
* **Special Refractories:** High-grade materials for extreme thermal environments.
* **Continuous Casting Refractories:** Specialized components for advanced steel manufacturing.
* **Special Monolithics:** Including **Castables**, **Plastic-based ramming mass**, and **gunning materials** used for furnace maintenance and lining.
**Pharmaceutical Formulations:**
Distinct from its heavy industrial operations, the company utilizes **100% indigenous technology** to manufacture pharmaceutical formulations.
* **R&D Integration:** Operations are supported by an in-house R&D wing focused on quality enhancement and productivity.
* **Technology Independence:** The company has not imported any technology in the last **3 years**, relying entirely on internal development to expand its product portfolio.
---
### **Strategic Market Positioning & Industry Drivers**
Raasi Refractories is highly cyclical, with its financial health intrinsically linked to the capital expenditure (CAPEX) and production cycles of heavy industries.
| Industry Segment | Impact on Demand |
| :--- | :--- |
| **Iron & Steel** | The primary driver, accounting for approximately **70%** of total refractory demand. |
| **Aluminum** | A high-growth secondary market due to substantial increases in domestic production. |
| **Cement & Glass** | Significant consumers of refractory bricks and monolithics for kiln operations. |
| **Petro-chemicals** | Specialized demand for high-performance thermal linings. |
**Strategic Vision:** The company is currently aligning its manufacturing capabilities with technological shifts in the steel industry, specifically focusing on the low-cost production of high-value special refractories to remain competitive against larger industry players.
---
### **Financial Performance & Capital Structure**
The company has recently experienced a significant contraction in scale, leading to a conservative fiscal approach characterized by the retention of earnings and a lack of dividend payouts.
**Key Financial Metrics (Comparative):**
| Metric (INR in Lakhs) | FY 2023-24 | FY 2022-23 | % Change |
| :--- | :--- | :--- | :--- |
| **Total Revenue** | **4,033.03** | **5,906.52** | **-31.72%** |
| **Profit After Tax (PAT)** | **29.63** | **86.43** | **-65.72%** |
**Capital and Liquidity Profile:**
* **Dividend & Reserves:** No dividend was recommended for **FY 2023-24**, and no funds were transferred to the **General Reserve**, as the board opted to deploy all profits back into operations.
* **Equity Structure:** The company has a single class of equity shares with a face value of **Rs. 10 per share**.
* **Debt & Deposits:** The company reported that it has **not accepted any deposits** and issued no **debentures or bonds** during the latest review period.
---
### **Governance, Leadership & Shareholding**
The company is currently undergoing a leadership transition intended to modernize its strategic direction and improve regulatory adherence.
**Major Shareholding (as of March 31, 2025):**
| Shareholder | No. of Shares | % of Holding |
| :--- | :--- | :--- |
| **Mr. Konda Laxmaiah** | **1,293,250** | **27.44%** |
| **M/s Ramlaxman Paraboiled Rice Mill P Ltd** | **1,098,320** | **23.30%** |
**Executive Leadership:**
* **Outgoing Leadership:** Led by **Sri. Konda Laxmaiah (Managing Director)**.
* **Incoming Leadership:** **Mr. Venkanna Konda** has been appointed as **Managing Director** for a **5-year term** effective **July 2025**, with a proposed annual remuneration of **₹1,00,00,000 (One Crore)**.
* **Auditors:** **M/s Narasimha Rao and Associates** serve as Statutory Auditors (tenure through **2028**), with **Mr. Pavan Kumar Bhattiprolu** acting as Secretarial Auditor.
---
### **Critical Risk Factors & Regulatory Challenges**
Investors should note significant operational and compliance-related headwinds that currently impact the company’s stability.
**1. Regulatory Non-Compliance & Listing Status:**
* **BSE Suspension:** Trading of Raasi Refractories shares is currently **suspended** on the **BSE** due to non-payment of **Annual Listing Fees** and penalties for **FY 2023-2024**.
* **Reporting Failures:** The company has consistently failed to file financial statements and compliance certificates on time, including the year ended **March 31, 2025**.
* **Board Negligence:** **Independent Directors** have failed to register with the **IICA databank**. Notably, Director **Mr. Rajendra Prasad Kandikattu** has failed to attend any Board Meetings for **three consecutive years**.
**2. Operational & Supply Chain Vulnerabilities:**
* **Raw Material Dependency:** High reliance on **China** for **Bauxite and Magnesia** exposes the company to logistical clogs and geopolitical volatility.
* **Energy Costs:** Severe **power shortages** and high electricity tariffs in Telangana have rendered several production units non-remunerative.
* **Labor & Compliance:** Management has failed to provide audit documentation for compliance with over **15 labor and environmental acts**, including the **Factories Act**.
**3. Financial & Statutory Risks:**
* **Statutory Defaults:** Regular delays in depositing undisputed dues such as **GST, Provident Fund, ESI, and Income Tax**, with some arrears outstanding for over **six months**.
* **Legal Violations:** Potential breaches of **Section 185** (loans to firms where directors are partners) and **Sections 73-76** (unauthorized borrowings) of the Companies Act.
* **Internal Controls:** The company failed to produce **Internal Audit Reports** for recent cycles and has not maintained an updated corporate website as required by **SEBI (LODR) Regulations**.